Peer-reviewedCC BY-NC-NDPlastic and reconstructive surgery. Global open
Process-dependent Analytical Differences Among Commercial Botulinum Neurotoxin Type A Formulations
- 1From the Hugel Medical Affairs, Seoul, Republic of Korea
- 2Hugel R&D Center, Chuncheon-si, Gangwon-do, Republic of Korea.
Related
- Analytical Agreement and Diagnostic Performance of a Commercial Point-of-Care Lipid Testing System for Lipid Profile and Atherogenic Ratios
- Acute Postprandial Glycemic Responses to Breads Made from Five Commercial Wheat-Flour Formulations: A Small Exploratory Nonrandomized Within-Participant Crossover Study
- Commercial Goat Cheeses Show No Differences in Postprandial Satiety During Caloric Restriction: A Randomized Controlled Pilot Trial
- History-dependent SEIR models: equivalent formulations, fractional foundation, and growth and decay principles
- Analytical Validation and Clinical Implementation of MedGenome HRD Assay: A Large Comparative Study Against Commercial HRD Assays in Ovarian Cancer
BibTeX
@article{choi2026processdependent,
title = {{Process-dependent Analytical Differences Among Commercial Botulinum Neurotoxin Type A Formulations}},
author = {Hyunjung Choi and Se Na Kim and Chang Ki Lee and Eunbee Jeong and Kyoung Yeol Park and Donghoon Oh and Seung Jun Shin},
journal = {Plastic and reconstructive surgery. Global open},
year = {2026},
month = oct,
url = {https://europepmc.org/article/PMC/PMC13671610},
note = {CC BY-NC-ND},
}
RIS
TY - JOUR
TI - Process-dependent Analytical Differences Among Commercial Botulinum Neurotoxin Type A Formulations
AU - Hyunjung Choi
AU - Se Na Kim
AU - Chang Ki Lee
AU - Eunbee Jeong
AU - Kyoung Yeol Park
AU - Donghoon Oh
AU - Seung Jun Shin
PY - 2026
DA - 2026/10/01
JO - Plastic and reconstructive surgery. Global open
UR - https://europepmc.org/article/PMC/PMC13671610
SN - 2169-7574
ER -